Protein discovery could improve type 2 diabetes treatment

A world first discovery of how a protein works in the liver could lead to a more effective type 2 diabetes drug. The researchers say such treatments will be more important than ever given that diabetes appears to be associated with poor prognosis in those with the COVID-19 infection. The University of Melbourne-led study found […]

Read More… from Protein discovery could improve type 2 diabetes treatment

Protein discovery could improve type 2 diabetes treatment

A world first discovery of how a protein works in the liver could lead to a more effective type 2 diabetes drug. The researchers say such treatments will be more important than ever given that diabetes appears to be associated with poor prognosis in those with the COVID-19 infection. The University of Melbourne-led study found […]

Read More… from Protein discovery could improve type 2 diabetes treatment

New app to forecast life expectancy

Researchers from the University of East Anglia have developed a new app that shows the effect of various medical and lifestyle factors on life expectancy. The Mylongevity app uses big data from anonymised electronic health records to calculate life expectancy – taking into account socio-demographic and health characteristics such as chronic diseases. While the app […]

Read More… from New app to forecast life expectancy

New app to forecast life expectancy

Researchers from the University of East Anglia have developed a new app that shows the effect of various medical and lifestyle factors on life expectancy. The Mylongevity app uses big data from anonymised electronic health records to calculate life expectancy – taking into account socio-demographic and health characteristics such as chronic diseases. While the app […]

Read More… from New app to forecast life expectancy

Pension-style solution is best fix for social care crisis

With more than 1 in 20 care home residents having died from coronavirus, the need to fix the crisis in social care for the elderly is more acute than ever. New analysis from the Centre for Policy Studies compares the leading models for social care reform. It finds that the system proposed by the Dilnot […]

Read More… from Pension-style solution is best fix for social care crisis

Pension-style solution is best fix for social care crisis

With more than 1 in 20 care home residents having died from coronavirus, the need to fix the crisis in social care for the elderly is more acute than ever. New analysis from the Centre for Policy Studies compares the leading models for social care reform. It finds that the system proposed by the Dilnot […]

Read More… from Pension-style solution is best fix for social care crisis

Steroid found to improve survival of critically ill COVID-19 patients

A new international study published today has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery. The study, led in the UK by Professor Anthony Gordon from Imperial College London with collaborators from the Intensive Care National Audit & Research Centre, found that patients receiving intensive care […]

Read More… from Steroid found to improve survival of critically ill COVID-19 patients

Steroid found to improve survival of critically ill COVID-19 patients

A new international study published today has shown that treating critically ill patients with COVID-19 with the steroid hydrocortisone improves their chances of recovery. The study, led in the UK by Professor Anthony Gordon from Imperial College London with collaborators from the Intensive Care National Audit & Research Centre, found that patients receiving intensive care […]

Read More… from Steroid found to improve survival of critically ill COVID-19 patients

Guidance on Brexit transition period

ABPI response to MHRA guidance for the end of the transition period The MHRA has published information for pharmaceutical companies preparing for the end of the Brexit transition period.​ The guidance provides some information on how to operate from 1 January 2021, including on licensing of medicines and devices, clinical trials, exporting active substances for […]

Read More… from Guidance on Brexit transition period

Guidance on Brexit transition period

ABPI response to MHRA guidance for the end of the transition period The MHRA has published information for pharmaceutical companies preparing for the end of the Brexit transition period.​ The guidance provides some information on how to operate from 1 January 2021, including on licensing of medicines and devices, clinical trials, exporting active substances for […]

Read More… from Guidance on Brexit transition period